Articles by Erin Slifka

The retail giant is adding full- and part-time positions at dozens of locations, with roles paying at least $15 an hour and including benefits, as it continues a hiring spree triggered by an online shopping surge during the pandemic.

Apple has long been a pioneer in marketing its products, but the tech giant is preparing for an unusual Covid-19 era event this week, one that isn’t expected to feature an iPhone or a packed crowd.

An agreement to sell tech-website network CNET to the digital-media holding company would come as ViacomCBS seeks to focus on video streaming.

Oracle won the bidding for the U.S. operations of the video-sharing app TikTok, a person familiar with the matter said, beating out Microsoft in a deal to salvage a social-media service that has been caught in the middle of a geopolitical standoff.

The impending sale of Arm Holdings to Nvidia for $40 billion could have wide-ranging implications for the global semiconductor industry.

The oil giant doubled down on oil and gas at what now looks to be the worst possible time. Investors are fleeing and workers are grumbling about the direction of a company some see as out of touch.

Central bankers want more stimulus from Congress because new research says spending, not lower rates, would do more to prevent deeper economic scars among the unemployed, businesses and state governments from the pandemic.

U.S. consumer prices rose in August due to higher costs for a range of items, a sign of firmer inflation as demand for goods continues to rebound from a coronavirus pandemic-induced downturn earlier this year.

Two high-ranking executives who oversaw Boeing’s development of the 737 MAX told House investigators the company’s design process wasn’t flawed despite two fatal crashes, a contrast to other company leaders’ concessions of past engineering errors.

The company has ended a pause in clinical trials for its experimental coronavirus vaccine in the U.K. after regulators concluded it was safe to do so. The trials were halted globally after a person who received the vaccine had an unexplained illness.